Patterns of care with regard to whole-brain radiotherapy technique and delivery among academic centers in the United States

P. Barry, M. Amsbaugh, C. Ziegler, A. Dragun
{"title":"Patterns of care with regard to whole-brain radiotherapy technique and delivery among academic centers in the United States","authors":"P. Barry, M. Amsbaugh, C. Ziegler, A. Dragun","doi":"10.12788/JCSO.0305","DOIUrl":null,"url":null,"abstract":"Despite the recent advances in systemic therapy, metastatic spread to the brain continues to be the most common neurologic complication of many cancers. The clinical incidence of brain metastases varies with primary cancer diagnosis, with estimates ranging from 1.2%-19.8%.1,2 Metastatic spread to the brain is even more prevalent at autopsy, with evidence of intracranial tumor being found in 26% of patients in some series.3 It is possible that the clinical incidence of metastatic disease to the brain will continue to increase as newer therapeutic agents improve survival and imaging techniques continue to improve. The management of brain metastases has changed rapidly as technological improvements have made treatment increasingly safe and efficacious. Traditionally, treatment consisted of radiotherapy to the whole brain, with or without surgical resection.4,5 More recently, stereotactic radiosurgery (SRS) has been adopted on the basis of evidence that it is safe and efficacious alone or in combination with radiotherapy to the whole brain.6 Further evidence is emerging that neurocognitive outcomes are improved when whole-brain radiotherapy (WBRT) is omitted, which possibly contributes to improved patient quality of life.7 Taking into account this and other data, the American Society for Radiation Oncology’s Choosing Wisely campaign now recommends not routinely adding WBRT to radiosurgery in patients with limited brain metastases.8 Despite this recommendation, many patients continue to benefit from WBRT, and it remains a common treatment in radiation oncology clinics across the US for several reasons. Many patients present with multiple brain metastases and are ineligible for radiosurgery. Even for technically eligible patients, WBRT has been shown to improve local control and decrease the rate of distant brain failure over radiosurgery alone.6 With higher rates of subsequent failures, patients receiving radiosurgery alone must adhere to more rigorous follow-up and imaging schedules, which can be difficult for many rural patients who have to travel long distances to centers.","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":"15 1","pages":"89-94"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of community and supportive oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12788/JCSO.0305","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Despite the recent advances in systemic therapy, metastatic spread to the brain continues to be the most common neurologic complication of many cancers. The clinical incidence of brain metastases varies with primary cancer diagnosis, with estimates ranging from 1.2%-19.8%.1,2 Metastatic spread to the brain is even more prevalent at autopsy, with evidence of intracranial tumor being found in 26% of patients in some series.3 It is possible that the clinical incidence of metastatic disease to the brain will continue to increase as newer therapeutic agents improve survival and imaging techniques continue to improve. The management of brain metastases has changed rapidly as technological improvements have made treatment increasingly safe and efficacious. Traditionally, treatment consisted of radiotherapy to the whole brain, with or without surgical resection.4,5 More recently, stereotactic radiosurgery (SRS) has been adopted on the basis of evidence that it is safe and efficacious alone or in combination with radiotherapy to the whole brain.6 Further evidence is emerging that neurocognitive outcomes are improved when whole-brain radiotherapy (WBRT) is omitted, which possibly contributes to improved patient quality of life.7 Taking into account this and other data, the American Society for Radiation Oncology’s Choosing Wisely campaign now recommends not routinely adding WBRT to radiosurgery in patients with limited brain metastases.8 Despite this recommendation, many patients continue to benefit from WBRT, and it remains a common treatment in radiation oncology clinics across the US for several reasons. Many patients present with multiple brain metastases and are ineligible for radiosurgery. Even for technically eligible patients, WBRT has been shown to improve local control and decrease the rate of distant brain failure over radiosurgery alone.6 With higher rates of subsequent failures, patients receiving radiosurgery alone must adhere to more rigorous follow-up and imaging schedules, which can be difficult for many rural patients who have to travel long distances to centers.
美国学术中心全脑放射治疗技术和治疗的护理模式
尽管最近在全身治疗方面取得了进展,但转移扩散到大脑仍然是许多癌症最常见的神经系统并发症。脑转移的临床发病率因原发癌的诊断而异,估计在1.2%-19.8%之间。脑转移扩散在尸检中更为普遍,有证据表明,在某些系列中,26%的患者发现颅内肿瘤随着新的治疗药物提高生存率和成像技术的不断改进,脑转移性疾病的临床发病率可能会继续增加。随着技术的进步,治疗越来越安全有效,脑转移瘤的治疗也发生了迅速的变化。传统上,治疗包括全脑放疗,伴或不伴手术切除。最近,立体定向放射外科(SRS)已被采用,基于证据表明,它是安全有效的单独或联合放射治疗全脑进一步的证据表明,当全脑放疗(WBRT)被省略时,神经认知结果得到改善,这可能有助于提高患者的生活质量考虑到这一点和其他数据,美国放射肿瘤学学会的“明智选择”运动现在建议,对于有限脑转移患者,放射手术中不要常规添加WBRT尽管有这样的建议,许多患者继续受益于WBRT,并且由于几个原因,它仍然是美国放射肿瘤学诊所的常见治疗方法。许多患者出现多发性脑转移,不适合放射手术。即使对于技术上符合条件的患者,与单纯放疗相比,WBRT已被证明可以改善局部控制并降低远端脑衰竭的发生率由于后续失败率较高,单独接受放射手术的患者必须遵守更严格的随访和成像计划,这对许多不得不长途跋涉到中心的农村患者来说可能很困难。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信